Dr. LeBlanc on Incorporating Palliative Care in the Treatment of Hematologic Malignancies

Thomas W. LeBlanc, MD
Published: Wednesday, Oct 11, 2017



Thomas W. LeBlanc, MD, MA, medical oncologist, palliative care physician, Duke Cancer Institute, gives advice on incorporating palliative care in the treatment of patients with hematologic malignancies.

LeBlanc says that medical oncologists should consider actively engaging palliative care specialists in the management of patients with hematologic malignancies.

It has been shown that patients undergoing stem cell transplant who were randomized to early concurrent palliative care experienced significant benefits in symptom management, quality of life, and a reduction in post-traumatic stress and depression.
 
SELECTED
LANGUAGE


Thomas W. LeBlanc, MD, MA, medical oncologist, palliative care physician, Duke Cancer Institute, gives advice on incorporating palliative care in the treatment of patients with hematologic malignancies.

LeBlanc says that medical oncologists should consider actively engaging palliative care specialists in the management of patients with hematologic malignancies.

It has been shown that patients undergoing stem cell transplant who were randomized to early concurrent palliative care experienced significant benefits in symptom management, quality of life, and a reduction in post-traumatic stress and depression.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Rapid Reviews in Oncology®: Practice-Changing Data in Acute Myeloid Leukemia: A Rapid Update From Atlanta OnlineDec 21, 20182.0
Community Practice Connections™: 2nd Annual European Congress on Hematology™: Focus on Lymphoid MalignanciesDec 30, 20182.0
Publication Bottom Border
Border Publication
x